Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)

China flag China · Delayed Price · Currency is CNY
25.55
+0.85 (3.44%)
At close: Jan 19, 2026
48.89%
Market Cap2.72B
Revenue (ttm)196.76M
Net Income (ttm)45.55M
Shares Out108.22M
EPS (ttm)0.42
PE Ratio59.69
Forward PEn/a
Dividend0.32 (1.27%)
Ex-Dividend DateSep 26, 2025
Volume2,576,950
Average Volume1,162,240
Open24.88
Previous Close24.70
Day's Range24.52 - 25.76
52-Week Range14.46 - 28.93
Beta0.46
RSI71.79
Earnings DateApr 25, 2026

About SHA:688163

Shanghai Serum Bio-Technology Co., Ltd. engages in the research, development, production, operation, and sales of antitoxin and antiserum products in China. It offers equine anti-tetanus immunoglobulin, anti-venin, and anti-rabies serum products. The company was founded in 1999 and is based in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 324
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688163
Full Company Profile

Financial Performance

In 2024, SHA:688163's revenue was 194.92 million, an increase of 2.51% compared to the previous year's 190.14 million. Earnings were 44.29 million, an increase of 14.23%.

Financial Statements